Update on pharmacogenetics in cancer chemotherapy

By Innocenti F.   Ratain M.J.  

European Journal of Cancer, Vol. 38, Iss. 5, 2002-03 ,pp. : 639-644

Elsevier

Access to resources Recommend Favorite

Pharmacogenetics and cancer chemotherapy

By Iyer L.   Ratain M.J.  

European Journal of Cancer, Vol. 34, Iss. 10, 1998-09 ,pp. : 1493-1499

Elsevier

Access to resources Recommend Favorite

Prognostic and Predictive Impact of the HER-2/ neu Extracellular Domain (ECD) in the Serum of Patients Treated with Chemotherapy for Metastatic Breast Cancer

By Müller Volkmar   Witzel Isabell   Lück Hans   Köhler Günter   Minckwitz Gunther   Möbus Volker   Sattler Daniel   Wilczak Waldemar   Löning Thomas   Jänicke Fritz   Pantel Klaus   Thomssen Christoph  

Breast Cancer Research and Treatment, Vol. 86, Iss. 1, 2004-07 ,pp. : 9-18

Springer Publishing Company

Access to resources Recommend Favorite

The role of nucleoside transporters in cancer chemotherapy with nucleoside drugs

By Zhang Jing   Visser Frank   King Karen   Baldwin Stephen   Young James   Cass Carol  

Cancer and Metastasis Reviews, Vol. 26, Iss. 1, 2007-03 ,pp. : 85-110

Springer Publishing Company

Access to resources Recommend Favorite

Duration of Chemotherapy for Early Stage Breast Cancer: Have We Reached the Limit? What is the Survival Impact of Amenorrhea?

By Hirsh Rebecca  

Current Treatment Options in Oncology, Vol. 11, Iss. 3-4, 2010-12 ,pp. : 59-62

Springer Publishing Company

Access to resources Recommend Favorite